2025-07-13 - Analysis Report
Okay, here's a report summarizing the provided data on Colgate-Palmolive Co (CL), formatted as requested.

```
## Colgate-Palmolive Co (CL) Stock Analysis

### 1. Relative Performance Analysis

Colgate-Palmolive Co (CL) is a global consumer products company focused on the production, distribution, and provision of household, health care, and personal care products.

**Key Metrics:**

*   **CL Cumulative Return:** 17.07%
*   **VOO (S&P 500) Cumulative Return:** 95.46%
*   **Spread:** -77.7%
*   **Spread Range (Max: 7.9, Min: -77.7):**
*   **Relative Spread Position:** 0.0

**Analysis:**

CL has significantly underperformed the S&P 500 (VOO) over the tracked period. The current spread of -77.7% indicates a substantial gap in cumulative returns. The relative spread position of 0.0 suggests that this underperformance is near the worst level observed in the data history.

**Alpha/Beta Analysis (Historical Rolling Windows):**

| Year       | CAGR   | MDD   | Alpha    | Beta   | Cap (B) |
|------------|--------|-------|----------|--------|---------|
| 2015-2017  | 13.0%  | 4.5%  | -16.0%   | 0.0    | 61.1    |
| 2016-2018  | -11.0% | 65.2% | -29.0%   | 0.1    | 48.2    |
| 2017-2019  | 7.0%   | 65.2% | -22.0%   | 0.1    | 55.8    |
| 2018-2020  | 18.0%  | 65.2% | -2.0%    | 0.6    | 69.3    |
| 2019-2021  | 30.0%  | 58.6% | -19.0%   | 0.7    | 69.2    |
| 2020-2022  | 7.0%   | 69.0% | 5.0%     | 0.7    | 63.9    |
| 2021-2023  | 6.0%   | 69.0% | -12.0%   | 0.8    | 64.6    |
| 2022-2024  | 13.0%  | 69.0% | -12.0%   | 0.8    | 73.7    |
| 2023-2025  | 4.0%   | 70.6% | -43.0%   | 0.3    | 72.6    |

**Observations:**

*   **Alpha:**  The consistently negative alpha values in most periods suggest Colgate-Palmolive has historically underperformed relative to its risk level.  The recent alpha is particularly negative.
*   **Beta:** The beta values, generally below 1, indicate that CL's price volatility is generally lower than that of the overall market.
*   **MDD:** High MDD figures, peaking at 70.6% in the 2023-2025 period, indicate significant drawdowns at times.
*   **CAGR:** CAGR varies over time, with more recent periods showing more modest growth.

### 2. Recent Stock Price Trends

*   **Current Price:** 89.58
*   **Previous Close:** 90.62
*   **Change:** -1.15
*   **5-Day Moving Average:** 91.45
*   **20-Day Moving Average:** 90.23
*   **60-Day Moving Average:** 91.18

**Analysis:**

The current price is below all three moving averages (5, 20, and 60-day), suggesting a short-term downtrend. The recent price change of -1.15 from the previous close indicates a continued downward pressure.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 58.11
*   **PPO:** 0.1056
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.34)
*   **Recent (20-Day) Relative Divergence Change:** 0.0 (Indicates Short-Term Decrease)
*   **Expected Return (%):** -3593.8

**Analysis:**

*   **MRI:** The MRI of 0.3294 indicates a "Low Risk" environment, which is a positive factor.
*   **RSI:** An RSI of 58.11 suggests the stock is neither overbought nor oversold, indicating neutral momentum.
*   **PPO:** The PPO is slightly positive, indicating that short-term price momentum is marginally stronger than long-term momentum.
*   **Hybrid Signal:** The hybrid signal suggests a buy signal, allocating 80% of cash, but with a caution flag due to the MRI.
*   **Recent Relative Divergence Change:** A decrease in relative divergence suggests that the stock's recent underperformance relative to the benchmark has worsened.
*   **Expected Return:** The significantly negative expected return (-3593.8%) indicates a highly unfavorable outlook for long-term investment compared to the S&P 500. The recent price drop of -1.15 may contribute to the negative sentiment.

### 4. Recent News & Significant Events

*   **[2025-07-12]:** Major business developments, regulatory changes, or market events affecting Colgate-Palmolive Co (CL).
*   **[2025-07-13]:** Analyst discussions about recent performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-11]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-09]:** Market experts highlighting both risks and opportunities and advising investors to monitor recent news.

**Analysis:**

The news snippets suggest that Colgate-Palmolive is experiencing volatility and is subject to market scrutiny. Investors should monitor company announcements and analyst opinions.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-04-25 | 0.85  | 4.91 B$  |
| 2024-10-25 | 0.90  | 5.03 B$  |
| 2024-07-26 | 0.89  | 5.06 B$  |
| 2024-04-26 | 0.83  | 5.07 B$  |
| 2025-04-25 | 0.83  | 5.07 B$  |

**Analysis:**

*   EPS has been fluctuating with no clear upward trend.
*   Revenue has shown a slight decrease from the highest point in Q2 2024 to the latest quarter.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31   | $4.91B     | 60.82%        |
| 2024-12-31   | $4.95B     | 60.30%        |
| 2024-09-30   | $5.03B     | 61.08%        |
| 2024-06-30   | $5.06B     | 60.62%        |
| 2024-03-31   | $5.07B     | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE        |
|--------------|-----------|------------|
| 2025-03-31   | $0.36B    | 190.08%    |
| 2024-12-31   | $0.21B    | 348.58%    |
| 2024-09-30   | $0.43B    | 169.43%    |
| 2024-06-30   | $0.12B    | 594.31%    |
| 2024-03-31   | $0.23B    | 296.96%    |

**Analysis:**

*   **Revenue & Profitability:** Revenue has shown a slight decline over the past year, while profit margins have remained relatively stable above 60%.
*   **Capital & Profitability:** Equity has fluctuated, and ROE has shown significant volatility. The high ROE values might warrant further investigation to ensure they are sustainable and not due to accounting anomalies.

### 7. Overall Summary

Based on the provided data, Colgate-Palmolive (CL) is currently exhibiting the following characteristics:

*   **Underperformance:** Significant underperformance compared to the S&P 500.
*   **Downtrend:** Short-term downtrend indicated by moving averages.
*   **Low Risk:** The Market Risk Indicator suggests a generally low-risk environment.
*   **Volatile News:** Recent news indicates market scrutiny and volatility.
*   **Mixed Financials:** Slight decline in revenue with stable profit margins, volatile ROE.
*   **Negative Outlook:** The highly negative expected return indicates a potentially unfavorable investment outlook.

**Recommendation:**

Given the underperformance, recent downtrend, and negative expected return, a cautious approach is warranted. Investors should closely monitor upcoming news and earnings reports, paying close attention to any factors that could improve the company's growth prospects and relative performance. Further analysis of the high ROE values is recommended to ensure sustainability.
```

**Explanation of Sections:**

*   **Section 1 (Relative Performance):** Compares CL's return to the S&P 500.  Calculates and interprets the spread and its relative position. Analyzes Alpha/Beta data.
*   **Section 2 (Stock Price Trends):**  Examines recent price movements and compares them to moving averages.
*   **Section 3 (Technical Indicators):** Interprets the Market Risk Indicator (MRI), RSI, PPO, Relative Divergence, and Expected Return.
*   **Section 4 (News):**  Acknowledges recent news events as potential factors.
*   **Section 5 (Earnings Analysis):**  Summarizes the provided EPS and Revenue data.
*   **Section 6 (Financial Information):**  Analyzes Revenue, Profit Margin, Equity and ROE data.
*   **Section 7 (Overall Summary):** Provides a concise summary of the findings and a general recommendation.

This report provides a structured overview of the provided data and its implications for Colgate-Palmolive's stock. Remember that this analysis is based solely on the information you provided and should not be considered investment advice. Always conduct thorough research and consult with a financial professional before making any investment decisions.
